Risk factors for relapse in ANCA-associated vasculitis (AAV) appear to differ depending on treatment phase, with higher levels of inflammation and immune activity linked to a greater risk of relapse after maintenance therapy is stopped. That’s according to a new, non-prespecified analysis of data from the Phase 3…
Discussion
Holidays can be wonderful — full of joy, connection, and tradition. They can also be complicated, especially for those of us living with vasculitis. This season, I was reminded of the importance of sharing openly with the people we love about what this disease means in our day-to-day lives.
Small particles loaded with manganese, an essential trace mineral, may help protect the kidneys from damage related to ANCA-associated vasculitis (AAV) by restoring antioxidant defenses and blocking a form of immune-mediated cell death. These findings come from experiments using neutrophils isolated from the blood of people with ANCA-associated glomerulonephritis…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
